StockData
Q32 Bio Inc. logo

Q32 Bio Inc. (QTTB) stock

QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$8.63+0.34 (+4.10%)

Close on Nov 17, 2026Market cap $256.91MP/E –Yield –

Q32 Bio enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Q32 Bio's enterprise value was $112.11M on Nov 11, 2026, against -$22.09M a year earlier. Over the last 5 years it ranged from -$246.98M to $458.89M, with a median of -$47.32M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$112.11M–
2025Dec 31, 2025-$8.19M–
2024Dec 31, 2024-$47.32M–
2023Dec 29, 2023-$106.63M–
2022Dec 30, 2022-$193.22M–
2021Dec 31, 2021-$165.00M–
2020Dec 31, 2020-$122.60M–
2019Dec 31, 2019-$171.02M–
2018Dec 31, 2018-$147.09M–

More Q32 Bio figures

See a number that looks wrong?